GlassScriptPhysician profile
Phuong N Tran
NPI 1881254274
$2,249.05
in general payments reported to CMS, 2019-2025
9 companies · $780 in 2025
The $780 reported for 2025 was more than what 81% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $38.66 · 2022: $309 · 2023: $513 · 2024: $608 · 2025: $780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,901.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,281.14 | 2021-2025 | Vemlidy, Epclusa, Livdelzi |
| Abbvie INC. | $297.47 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $174.01 | 2023-2024 | Dificid |
| Amgen INC. | $128.42 | 2025 | Evenity |
| Takeda Pharmaceuticals U.S.A., INC. | $114.17 | 2021-2025 | Entyvio |
| Organon LLC | $92.74 | 2023-2025 | Hadlima, Renflexis |
| Genzyme Corporation | $74.39 | 2022-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $47.95 | 2025 | Caplyta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.76 | 2024 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phuong Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.